Inactive Instrument

Highlights OXFORD BIOMEDICA Swiss Exchange

Equities

OXB

GB0006648157

Highlights

Unlock all the news: Be the first to know and act before the market!

Avon Protection wins UK MoD supply deal; Molten Ventures up	09/05	AN
FTSE 100 as investors look to Fed rate decision	29/04	AN
Oxford BioMedica bullish; Petrofac slumps	29/04	AN
Earnings Flash (OXB.L) OXFORD BIOMEDICA Reports FY23 Revenue GBP89.5M	29/04	MT
Oxford Biomedica plc Reiterates Earnings Guidance for the Year 2024	29/04	CI
Oxford Biomedica plc Reports Earnings Results for the Full Year Ended December 31, 2023	29/04	CI
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	20/03	AN
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs	20/03	MT
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract	05/03	AN
Oxford Biomedica plc Provides Earnings Guidance for the Year Ended December 31, 2023 and for the Fiscal Year 2024	05/03	CI
EnSilica hires new chief financial officer from Oxford Biomedica	05/02	AN
Oxford Biomedica Completes EUR15 Million ABL Europe Acquisition	29/01	MT
Institut Merieux ups stake in Oxford BioMedica toward 10%	29/01	AN
Oxford Biomedica plc completed the acquisition of additional 3.2% stake in ABL EUROPE S.A.S. from TSGH ?6.1 million	29/01	CI
Oxford BioMedica posts optimistic outlook on uptick in contract value	08/12	AN
Oxford Biomedica plc Provides Business Update	07/12	CI
Oxford Biomedica to Buy ABL Europe from Institut Mérieux	04/12	MT
Oxford BioMedica buys ABL Europe for consideration of EUR15 million	04/12	AN
Oxford Biomedica plc entered into a sale and purchase agreement to acquire additional 3.2% stake in ABL EUROPE S.A.S. from TSGH.	04/12	CI
Oxford Biomedica plc entered into a sale and purchase agreement to acquire ABL EUROPE S.A.S. from TSGH for ?15 million.	04/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights OXFORD BIOMEDICA Swiss Exchange

Equities

OXB

GB0006648157

Highlights

Filters